A drug can have perfect PD properties—high affinity, perfect efficacy—but fail utterly if it cannot reach its target. This is the tragedy of many promising compounds. is the quantitative study of drug absorption, distribution, metabolism, and excretion (ADME).
The Backbone of Medicine: Why Pharmacology is the True Hero of Drug Discovery & Development
How genetic variation influences individual drug response (e.g., CYP450 polymorphisms affecting metabolism). pharmacology in drug discovery and development
The process begins with selecting a biological target (e.g., a specific protein) believed to be involved in a disease process. Pharmacologists use a wide range of tools, from human genetics to "omics" technologies (genomics, proteomics), to identify and validate these targets. A validated target should be , meaning it has a site where a small molecule or biologic can bind and modulate its activity.
Once a target is validated, thousands of chemical compounds are screened to identify "hits" or lead compounds that show promising biological activity. A drug can have perfect PD properties—high affinity,
We now understand that a drug isn't just a molecule; it is a molecule in a specific genetic background .
A wide TI (e.g., Penicillin: TI > 100) is safe. A narrow TI (e.g., Digoxin for heart failure: TI ~ 2) is dangerous. Pharmacologists generate DRCs for both efficacy and toxicity in at least two animal species (typically rodent and non-rodent) before regulatory filing. The Backbone of Medicine: Why Pharmacology is the
The Architect of Modern Medicine: Pharmacology in Drug Discovery and Development
QSP is increasingly used to address high costs and high failure rates in drug development [5.5]. 4. Key Challenges in Pharmacological Development